Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ocean Tomo China is the specialized Chinese division of Ocean Tomo, a leading intellectual property merchant bank and a subsidiary of J.S. Held. Established through a strategic collaboration with Sinofaith IP Group, the firm provides intellectual property valuation, management, and advisory services tailored to the Chinese market. Within the healthcare and life sciences sectors, Ocean Tomo China assists clients with complex matters such as Hatch-Waxman disputes, pharmaceutical antitrust consulting, and the valuation of clinical-stage biotechnology assets. The company supports both domestic Chinese firms expanding internationally and global corporations navigating the Chinese IP landscape, offering services that include IP brokerage, licensing assistance, and patent-focused business intelligence. By leveraging its parent company's global expertise, Ocean Tomo China facilitates cross-border technology transfer and provides expert testimony in high-stakes IP litigation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ocean Tomo China.